These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 9281615)

  • 21. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties.
    Sullivan JP; Donnelly-Roberts D; Briggs CA; Anderson DJ; Gopalakrishnan M; Xue IC; Piattoni-Kaplan M; Molinari E; Campbell JE; McKenna DG; Gunn DE; Lin NH; Ryther KB; He Y; Holladay MW; Wonnacott S; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1997 Oct; 283(1):235-46. PubMed ID: 9336329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro regulation of serotonin transporter activity by protein kinase A and nicotinic acetylcholine receptors in the prefrontal cortex of rats.
    Awtry TL; Frank JG; Werling LL
    Synapse; 2006 May; 59(6):342-9. PubMed ID: 16463401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Agonist-induced hump current production in heterologously-expressed human alpha4beta2-nicotinic acetylcholine receptors.
    Liu Q; Yu KW; Chang YC; Lukas RJ; Wu J
    Acta Pharmacol Sin; 2008 Mar; 29(3):305-19. PubMed ID: 18298895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
    Flores CM; Rogers SW; Pabreza LA; Wolfe BB; Kellar KJ
    Mol Pharmacol; 1992 Jan; 41(1):31-7. PubMed ID: 1732720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes.
    Tasso B; Canu Boido C; Terranova E; Gotti C; Riganti L; Clementi F; Artali R; Bombieri G; Meneghetti F; Sparatore F
    J Med Chem; 2009 Jul; 52(14):4345-57. PubMed ID: 19548687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
    de Moura FB; McMahon LR
    Psychopharmacology (Berl); 2017 Mar; 234(5):781-792. PubMed ID: 28028600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
    Clarke PB; Reuben M
    Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methadone increases intracellular calcium in SH-SY5Y and SH-EP1-halpha7 cells by activating neuronal nicotinic acetylcholine receptors.
    Pakkanen JS; Nousiainen H; Yli-Kauhaluoma J; Kylänlahti I; Möykkynen T; Korpi ER; Peng JH; Lukas RJ; Ahtee L; Tuominen RK
    J Neurochem; 2005 Sep; 94(5):1329-41. PubMed ID: 16000156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.
    Smulders CJ; Zwart R; Bermudez I; van Kleef RG; Groot-Kormelink PJ; Vijverberg HP
    Eur J Pharmacol; 2005 Feb; 509(2-3):97-108. PubMed ID: 15733544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices.
    Grinevich VP; Crooks PA; Sumithran SP; Haubner AJ; Ayers JT; Dwoskin LP
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1011-20. PubMed ID: 12766255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nicotinic receptor binding sites in rat primary neuronal cells in culture: characterization and their regulation by chronic nicotine.
    Dávila-García MI; Houghtling RA; Qasba SS; Kellar KJ
    Brain Res Mol Brain Res; 1999 Mar; 66(1-2):14-23. PubMed ID: 10095073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
    Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C
    Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices.
    Sacaan AI; Dunlop JL; Lloyd GK
    J Pharmacol Exp Ther; 1995 Jul; 274(1):224-30. PubMed ID: 7542334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice.
    Damaj MI; Fei-Yin M; Dukat M; Glassco W; Glennon RA; Martin BR
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1058-65. PubMed ID: 9495867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of alpha-bungarotoxin sites in chromaffin cells in culture by nicotinic receptor ligands, K+, and cAMP.
    Geertsen S; Afar R; Trifaró JM; Quik M
    Mol Pharmacol; 1988 Oct; 34(4):549-56. PubMed ID: 2459593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes.
    Lu Y; Grady S; Marks MJ; Picciotto M; Changeux JP; Collins AC
    J Pharmacol Exp Ther; 1998 Nov; 287(2):648-57. PubMed ID: 9808692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and optimization of a high-throughput electrophysiology assay for neuronal alpha4beta2 nicotinic receptors.
    Sidach SS; Fedorov NB; Lippiello PM; Bencherif M
    J Neurosci Methods; 2009 Aug; 182(1):17-24. PubMed ID: 19481112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of human alpha7 nicotinic receptors by chronic treatment with activator and antagonist ligands.
    Molinari EJ; Delbono O; Messi ML; Renganathan M; Arneric SP; Sullivan JP; Gopalakrishnan M
    Eur J Pharmacol; 1998 Apr; 347(1):131-9. PubMed ID: 9650859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marked up-regulation of the beta-bungarotoxin site in adrenal chromaffin cells by specific nicotinic antagonists.
    Quik M; Geertsen S; Trifaró JM
    Mol Pharmacol; 1987 Apr; 31(4):385-91. PubMed ID: 3574287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.